INTRODUCTION: Transvenous ventricular pacing leads across the tricuspid valve may cause or exacerbate tricuspid regurgitation (TR). The literature in adults is inconclusive and no studies have investigated the association between pacing leads and TR in children or congenital heart disease patients. METHODS AND RESULTS: A retrospective chart review was conducted at a large children's hospital, yielding 123 patients with initial placement of a transvenous lead across their tricuspid valve that had adequate echocardiographic data for review. The median age was 16 years (range 2-52) at time of lead placement. The pre-procedure echo was compared both to the first echo after lead placement and the most recent echo. Median time was 242 days from implant to first echo, and 827 days to most recent echo. There was no difference in TR between the pre-procedure echo and first follow-up echo (p = NS). However, TR was more likely to progress mildly between the pre-procedure echo and the most recent echo (p < 0.02) with a mean increase from 1.54 to 1.69 on a 0 to 4 ordinal scale. There were 76 pts (62%) with CHD. Mean pre-procedure TR was 1.82 in right-sided valvular CHD (e.g., tetralogy of Fallot, repaired AV canal) vs. 1.43 without right-sided CHD (p < 0.01). CONCLUSIONS: In patients with transvenous ventricular leads across the tricuspid valve, echocardiography demonstrates a small, but statistically significant change in TR. The detected change is minimal, suggesting that there is little impact of transvenous leads on TR, even in growing children or patients with right-sided structural heart disease.
INTRODUCTION: Transvenous ventricular pacing leads across the tricuspid valve may cause or exacerbate tricuspid regurgitation (TR). The literature in adults is inconclusive and no studies have investigated the association between pacing leads and TR in children or congenital heart diseasepatients. METHODS AND RESULTS: A retrospective chart review was conducted at a large children's hospital, yielding 123 patients with initial placement of a transvenous lead across their tricuspid valve that had adequate echocardiographic data for review. The median age was 16 years (range 2-52) at time of lead placement. The pre-procedure echo was compared both to the first echo after lead placement and the most recent echo. Median time was 242 days from implant to first echo, and 827 days to most recent echo. There was no difference in TR between the pre-procedure echo and first follow-up echo (p = NS). However, TR was more likely to progress mildly between the pre-procedure echo and the most recent echo (p < 0.02) with a mean increase from 1.54 to 1.69 on a 0 to 4 ordinal scale. There were 76 pts (62%) with CHD. Mean pre-procedure TR was 1.82 in right-sided valvular CHD (e.g., tetralogy of Fallot, repaired AV canal) vs. 1.43 without right-sided CHD (p < 0.01). CONCLUSIONS: In patients with transvenous ventricular leads across the tricuspid valve, echocardiography demonstrates a small, but statistically significant change in TR. The detected change is minimal, suggesting that there is little impact of transvenous leads on TR, even in growing children or patients with right-sided structural heart disease.
Authors: Gabriel Gregoratos; Jonathan Abrams; Andrew E Epstein; Roger A Freedman; David L Hayes; Mark A Hlatky; Richard E Kerber; Gerald V Naccarelli; Mark H Schoenfeld; Michael J Silka; Stephen L Winters; Raymond I Gibbons; Elliott M Antman; Joseph S Alpert; Loren F Hiratzka; David P Faxon; Alice K Jacobs; Valentin Fuster; Sidney C Smith Journal: J Cardiovasc Electrophysiol Date: 2002-11
Authors: Said B Iskandar; S Ann Jackson; Stephen Fahrig; Bassam K Mechleb; Israel D Garcia Journal: Echocardiography Date: 2006-09 Impact factor: 1.724
Authors: Yaniv Bar-Cohen; Charles I Berul; Mark E Alexander; Elizabeth B Fortescue; Edward P Walsh; John K Triedman; Frank Cecchin Journal: J Cardiovasc Electrophysiol Date: 2006-07
Authors: R J Kuczmarski; C L Ogden; L M Grummer-Strawn; K M Flegal; S S Guo; R Wei; Z Mei; L R Curtin; A F Roche; C L Johnson Journal: Adv Data Date: 2000-06-08
Authors: Elizabeth B Fortescue; Charles I Berul; Frank Cecchin; Edward P Walsh; John K Triedman; Mark E Alexander Journal: Heart Rhythm Date: 2004-07 Impact factor: 6.343
Authors: Giselle A Baquero; Pradeep Yadav; Joshua B Skibba; Javier E Banchs; Latoya N Linton-Frazier; Eugene J Lengerich; Soraya M Samii; Erica Penny-Peterson; Deborah L Wolbrette; Jerry C Luck; Gerald V Naccarelli; Mario D Gonzalez Journal: J Interv Card Electrophysiol Date: 2013-12 Impact factor: 1.900
Authors: Katarzyna Wiechecka; Bartosz Wiechecki; Agnieszka Kapłon-Cieślicka; Agata Tymińska; Monika Budnik; Dominika Hołowaty; Krzysztof Jakubowski; Marcin Michalak; Elżbieta Świętoń; Przemysław Stolarz; Roman Steckiewicz; Marcin Grabowski; Piotr Scisło; Janusz Kochanowski; Krzysztof J Filipiak; Grzegorz Opolski Journal: Cardiol J Date: 2019-06-21 Impact factor: 2.737
Authors: Daniel P Rothschild; James A Goldstein; Nathan Kerner; Amr E Abbas; Meet Patel; Wai Shun Wong Journal: J Interv Card Electrophysiol Date: 2017-07-06 Impact factor: 1.900
Authors: Masoud Sadreddini; Michelle J Haroun; Lisanne Buikema; Carlos Morillo; Sebastian Ribas; Syamkumar Divakaramenon; Stuart J Connolly; Robby Nieuwlaat; Eva M Lonn; Jeff S Healey; Hisham Dokainish Journal: Open Cardiovasc Med J Date: 2014-12-31
Authors: Elisa Ebrille; Christopher V DeSimone; Vaibhav R Vaidya; Anwar A Chahal; Vuyisile T Nkomo; Samuel J Asirvatham Journal: Indian Pacing Electrophysiol J Date: 2016-03-04
Authors: Anna Polewczyk; Wojciech Jacheć; Dorota Nowosielecka; Andrzej Tomaszewski; Wojciech Brzozowski; Dorota Szczęśniak-Stańczyk; Krzysztof Duda; Andrzej Kutarski Journal: J Clin Med Date: 2021-12-24 Impact factor: 4.241